Skip to main content
NCBI home page
Gut logoLink to Gut
. 2002 May;50(Suppl 4):iv72–iv78. doi: 10.1136/gut.50.suppl_4.iv72

Dyspepsia: management guidelines for the millennium

N Talley
PMCID: PMC1867696  PMID: 11953354

Full Text

The Full Text of this article is available as a PDF (166.1 KB).

Figure 1 .

Figure 1

Open in a new tab

Recommended decision pathway for the management of dyspepsia: (A) diagnosis; (B) initial therapy; (C) long term management. *Age cut off is dependent on local incidence of gastric cancer. IBS, irritable bowel syndrome; PPI, proton pump inhibitor; UBT, urea breath test.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agréus L., Talley N. Challenges in managing dyspepsia in general practice. BMJ. 1997 Nov 15;315(7118):1284–1288. doi: 10.1136/bmj.315.7118.1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut. 1999 Apr;44 (Suppl 2):S1–16. doi: 10.1136/gut.44.2008.s1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Axon A. T., Bell G. D., Jones R. H., Quine M. A., McCloy R. F. Guidelines on appropriate indications for upper gastrointestinal endoscopy. Working Party of the Joint Committee of the Royal College of Physicians of London, Royal College of Surgeons of England, Royal College of Anaesthetists, Association of Surgeons, the British Society of Gastroenterology, and the Thoracic Society of Great Britain. BMJ. 1995 Apr 1;310(6983):853–856. doi: 10.1136/bmj.310.6983.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blum A. L., Talley N. J., O'Moráin C., van Zanten S. V., Labenz J., Stolte M., Louw J. A., Stubberöd A., Theodórs A., Sundin M. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med. 1998 Dec 24;339(26):1875–1881. doi: 10.1056/NEJM199812243392602. [DOI] [PubMed] [Google Scholar]
  5. Bytzer P., Hansen J. M., Havelund T., Malchow-Møller A., Schaffalitzky de Muckadell O. B. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol. 1996 Apr;8(4):359–363. doi: 10.1097/00042737-199604000-00014. [DOI] [PubMed] [Google Scholar]
  6. Bytzer P., Hansen J. M., Schaffalitzky de Muckadell O. B. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994 Apr 2;343(8901):811–816. doi: 10.1016/s0140-6736(94)92023-0. [DOI] [PubMed] [Google Scholar]
  7. Bytzer P., Hansen J. M., Schaffalitzky de Muckadell O. B., Malchow-Møller A. Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models. Scand J Gastroenterol. 1997 Feb;32(2):118–125. doi: 10.3109/00365529709000181. [DOI] [PubMed] [Google Scholar]
  8. Carlsson R., Dent J., Bolling-Sternevald E., Johnsson F., Junghard O., Lauritsen K., Riley S., Lundell L. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998 Oct;33(10):1023–1029. doi: 10.1080/003655298750026697. [DOI] [PubMed] [Google Scholar]
  9. Christie J., Shepherd N. A., Codling B. W., Valori R. M. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut. 1997 Oct;41(4):513–517. doi: 10.1136/gut.41.4.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cullen D., Bardhan K. D., Eisner M., Kogut D. G., Peacock R. A., Thomson J. M., Hawkey C. J. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther. 1998 Feb;12(2):135–140. doi: 10.1046/j.1365-2036.1998.00288.x. [DOI] [PubMed] [Google Scholar]
  11. Ekström P., Carling L., Wetterhus S., Wingren P. E., Anker-Hansen O., Lundegårdh G., Thorhallsson E., Unge P. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol. 1996 Aug;31(8):753–758. doi: 10.3109/00365529609010347. [DOI] [PubMed] [Google Scholar]
  12. Fendrick A. M., Chernew M. E., Hirth R. A., Bloom B. S. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 1995 Aug 15;123(4):260–268. doi: 10.7326/0003-4819-123-4-199508150-00003. [DOI] [PubMed] [Google Scholar]
  13. Fraitag B., Homerin M., Hecketsweiler P. Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci. 1994 May;39(5):1072–1077. doi: 10.1007/BF02087560. [DOI] [PubMed] [Google Scholar]
  14. Fraser A. G., Ali M. R., McCullough S., Yeates N. J., Haystead A. Diagnostic tests for Helicobacter pylori--can they help select patients for endoscopy? N Z Med J. 1996 Mar 22;109(1018):95–98. [PubMed] [Google Scholar]
  15. Gilvarry J., Buckley M. J., Beattie S., Hamilton H., O'Morain C. A. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol. 1997 Jun;32(6):535–540. doi: 10.3109/00365529709025095. [DOI] [PubMed] [Google Scholar]
  16. Goves J., Oldring J. K., Kerr D., Dallara R. G., Roffe E. J., Powell J. A., Taylor M. D. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice. Aliment Pharmacol Ther. 1998 Feb;12(2):147–157. doi: 10.1046/j.1365-2036.1998.0284f.x. [DOI] [PubMed] [Google Scholar]
  17. Haug T. T., Wilhelmsen I., Svebak S., Berstad A., Ursin H. Psychotherapy in functional dyspepsia. J Psychosom Res. 1994 Oct;38(7):735–744. doi: 10.1016/0022-3999(94)90026-4. [DOI] [PubMed] [Google Scholar]
  18. Hawkey C. J., Karrasch J. A., Szczepañski L., Walker D. G., Barkun A., Swannell A. J., Yeomans N. D. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998 Mar 12;338(11):727–734. doi: 10.1056/NEJM199803123381105. [DOI] [PubMed] [Google Scholar]
  19. Hawkey C. J. Practical management: a keypad-based interactive session. Am J Med. 1998 Mar 30;104(3A):89S–95S. doi: 10.1016/s0002-9343(97)00219-2. [DOI] [PubMed] [Google Scholar]
  20. Heading R. C., Wager E., Tooley P. J. Reliability of symptom assessment in dyspepsia. Eur J Gastroenterol Hepatol. 1997 Aug;9(8):779–781. doi: 10.1097/00042737-199708000-00008. [DOI] [PubMed] [Google Scholar]
  21. Heaney A., Collins J. S., Watson R. G., McFarland R. J., Bamford K. B., Tham T. C. A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut. 1999 Aug;45(2):186–190. doi: 10.1136/gut.45.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Howden C. W. For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection? Gastroenterology. 1997 Dec;113(6 Suppl):S107–S112. doi: 10.1016/s0016-5085(97)80022-4. [DOI] [PubMed] [Google Scholar]
  23. Hunt R., Thomson A. B. Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. Can J Gastroenterol. 1998 Jan-Feb;12(1):31–41. doi: 10.1155/1998/170180. [DOI] [PubMed] [Google Scholar]
  24. Jones R. H., Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther. 1997 Jun;11(3):541–546. doi: 10.1046/j.1365-2036.1997.00179.x. [DOI] [PubMed] [Google Scholar]
  25. Kurata J. H., Nogawa A. N., Chen Y. K., Parker C. E. Dyspepsia in primary care: perceived causes, reasons for improvement, and satisfaction with care. J Fam Pract. 1997 Mar;44(3):281–288. [PubMed] [Google Scholar]
  26. Lam S. K., Talley N. J. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol. 1998 Jan;13(1):1–12. doi: 10.1111/j.1440-1746.1998.tb00537.x. [DOI] [PubMed] [Google Scholar]
  27. Lassen A. T., Pedersen F. M., Bytzer P., Schaffalitzky de Muckadell O. B. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet. 2000 Aug 5;356(9228):455–460. doi: 10.1016/s0140-6736(00)02553-8. [DOI] [PubMed] [Google Scholar]
  28. Lind T., Havelund T., Lundell L., Glise H., Lauritsen K., Pedersen S. A., Anker-Hansen O., Stubberöd A., Eriksson G., Carlsson R. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial. Aliment Pharmacol Ther. 1999 Jul;13(7):907–914. doi: 10.1046/j.1365-2036.1999.00564.x. [DOI] [PubMed] [Google Scholar]
  29. Loy C. T., Irwig L. M., Katelaris P. H., Talley N. J. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. Am J Gastroenterol. 1996 Jun;91(6):1138–1144. [PubMed] [Google Scholar]
  30. Lydeard S., Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract. 1989 Dec;39(329):495–498. [PMC free article] [PubMed] [Google Scholar]
  31. Malfertheiner P., Mégraud F., O'Morain C., Hungin A. P. S., Jones R., Axon A., Graham D. Y., Tytgat G., European Helicobacter Pylori Study Group (EHPSG) Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002 Feb;16(2):167–180. doi: 10.1046/j.1365-2036.2002.01169.x. [DOI] [PubMed] [Google Scholar]
  32. Mason I., Millar L. J., Sheikh R. R., Evans W. M., Todd P. L., Turbitt M. L., Taylor M. D. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. Aliment Pharmacol Ther. 1998 Mar;12(3):263–271. doi: 10.1046/j.1365-2036.1998.00282.x. [DOI] [PubMed] [Google Scholar]
  33. Maxton D. G., Morris J., Whorwell P. J. Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia? Aliment Pharmacol Ther. 1996 Aug;10(4):595–599. doi: 10.1046/j.1365-2036.1996.30172000.x. [DOI] [PubMed] [Google Scholar]
  34. McColl K. E., el-Nujumi A., Murray L., el-Omar E., Gillen D., Dickson A., Kelman A., Hilditch T. E. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut. 1997 Mar;40(3):302–306. doi: 10.1136/gut.40.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McColl K., Murray L., El-Omar E., Dickson A., El-Nujumi A., Wirz A., Kelman A., Penny C., Knill-Jones R., Hilditch T. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998 Dec 24;339(26):1869–1874. doi: 10.1056/NEJM199812243392601. [DOI] [PubMed] [Google Scholar]
  36. Meineche-Schmidt V., Talley N. J., Pap A., Kordecki H., Schmid V., Ohlsson L., Wahlqvist P., Wiklund I., Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study. Scand J Gastroenterol. 1999 Jun;34(6):566–574. doi: 10.1080/003655299750026010. [DOI] [PubMed] [Google Scholar]
  37. Mertz H., Fass R., Kodner A., Yan-Go F., Fullerton S., Mayer E. A. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol. 1998 Feb;93(2):160–165. doi: 10.1111/j.1572-0241.1998.00160.x. [DOI] [PubMed] [Google Scholar]
  38. Ofman J. J., Etchason J., Fullerton S., Kahn K. L., Soll A. H. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med. 1997 Feb 15;126(4):280–291. doi: 10.7326/0003-4819-126-4-199702150-00004. [DOI] [PubMed] [Google Scholar]
  39. Patel P., Khulusi S., Mendall M. A., Lloyd R., Jazrawi R., Maxwell J. D., Northfield T. C. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet. 1995 Nov 18;346(8986):1315–1318. doi: 10.1016/s0140-6736(95)92340-3. [DOI] [PubMed] [Google Scholar]
  40. Read N. W., Abitbol J. L., Bardhan K. D., Whorwell P. J., Fraitag B. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut. 1997 Nov;41(5):664–668. doi: 10.1136/gut.41.5.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Talley N. J., Axon A., Bytzer P., Holtmann G., Lam S. K., Van Zanten S. Management of uninvestigated and functional dyspepsia: a Working Party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther. 1999 Sep;13(9):1135–1148. doi: 10.1046/j.1365-2036.1999.00584.x. [DOI] [PubMed] [Google Scholar]
  42. Talley N. J., Boyce P., Jones M. Dyspepsia and health care seeking in a community: How important are psychological factors? Dig Dis Sci. 1998 May;43(5):1016–1022. doi: 10.1023/a:1018878717715. [DOI] [PubMed] [Google Scholar]
  43. Talley N. J., Janssens J., Lauritsen K., Rácz I., Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ. 1999 Mar 27;318(7187):833–837. doi: 10.1136/bmj.318.7187.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Talley N. J., Lam S. K., Goh K. L., Fock K. M. Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific Working Party on Functional Dyspepsia. J Gastroenterol Hepatol. 1998 Apr;13(4):335–353. doi: 10.1111/j.1440-1746.1998.tb00644.x. [DOI] [PubMed] [Google Scholar]
  45. Talley N. J., Lambert J. R., Howell S., Xia H. H., Lin S. K., Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther. 1998 Jul;12(7):641–645. doi: 10.1046/j.1365-2036.1998.00363.x. [DOI] [PubMed] [Google Scholar]
  46. Talley N. J., Meineche-Schmidt V., Paré P., Duckworth M., Räisänen P., Pap A., Kordecki H., Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov;12(11):1055–1065. doi: 10.1046/j.1365-2036.1998.00410.x. [DOI] [PubMed] [Google Scholar]
  47. Talley N. J., Silverstein M. D., Agréus L., Nyrén O., Sonnenberg A., Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology. 1998 Mar;114(3):582–595. doi: 10.1016/s0016-5085(98)70542-6. [DOI] [PubMed] [Google Scholar]
  48. Talley N. J., Stanghellini V., Heading R. C., Koch K. L., Malagelada J. R., Tytgat G. N. Functional gastroduodenal disorders. Gut. 1999 Sep;45 (Suppl 2):II37–II42. doi: 10.1136/gut.45.2008.ii37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Talley N. J. Visceral analgesics and functional dyspepsia: have we found the Holy Grail? Gut. 1997 Nov;41(5):717–718. doi: 10.1136/gut.41.5.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Talley N. J., Weaver A. L., Tesmer D. L., Zinsmeister A. R. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993 Nov;105(5):1378–1386. doi: 10.1016/0016-5085(93)90142-y. [DOI] [PubMed] [Google Scholar]
  51. Talley N. J., Zinsmeister A. R., Schleck C. D., Melton L. J., 3rd Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr;102(4 Pt 1):1259–1268. [PubMed] [Google Scholar]
  52. Vaira D., Stanghellini V., Menegatti M., Palli D., Corinaldesi R., Miglioli M. Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy. 1997 Sep;29(7):595–601. doi: 10.1055/s-2007-1004263. [DOI] [PubMed] [Google Scholar]
  53. Wiklund I., Glise H., Jerndal P., Carlsson J., Talley N. J. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc. 1998 Jun;47(6):449–454. doi: 10.1016/s0016-5107(98)70243-3. [DOI] [PubMed] [Google Scholar]
  54. Williams B., Luckas M., Ellingham J. H., Dain A., Wicks A. C. Do young patients with dyspepsia need investigation? Lancet. 1988 Dec 10;2(8624):1349–1351. doi: 10.1016/s0140-6736(88)90879-3. [DOI] [PubMed] [Google Scholar]
  55. Yeomans N. D., Tulassay Z., Juhász L., Rácz I., Howard J. M., van Rensburg C. J., Swannell A. J., Hawkey C. J. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998 Mar 12;338(11):719–726. doi: 10.1056/NEJM199803123381104. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES